Has Antonio Halais Frangieh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $207,848 in general payments to Antonio Halais Frangieh, MD across 282 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Antonio Halais Frangieh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Antonio Halais Frangieh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Antonio Halais Frangieh, MD

Interventional Cardiology · Orange, CANPI 1003558420

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $178,311 of the $207,848 with a category attached, or 85.8%. Edwards Lifesciences accounts for 92.3% of it on its own, with 15 other manufacturers making up the rest. Among interventional cardiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$207,848in general payments, 2019–2025

Across 282 payments — averaging $737.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$192K
Biosense Webster, Inc.$11K
Abbott$3K
Medtronic$555
Abiomed$347
Shockwave Medical, Inc$205
plus $773 from 10 others

$386,254in research payments, 2019–2025

Across 40 payments — averaging $9656.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$386K

What the payments were for

Consulting fees$178,31186%
Speaking & faculty fees$6,2503%
Travel & lodging$11,6076%
Food & beverage$11,6166%
Education$260%
Entertainment$380%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	218	$191,941
Biosense Webster, Inc.	9	$10,817
Abbott	29	$3,210
Medtronic	8	$555
Abiomed	4	$347
Shockwave Medical, Inc	2	$205
Bracco Diagnostics Inc.	1	$192
Jenavalve Technology, Inc.	1	$127
Novartis	1	$114
Opsens Inc.	2	$103
Philips North America LLC	2	$93
Terumo Medical Corporation	1	$40
E.r. Squibb & Sons, L.L.C.	1	$28
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$27
W. L. Gore & Associates, Inc.	1	$26
Boston Scientific	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$80,036
PASCAL$62,182
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$13,240
Carto 3$7,875
SAPIEN 3 Ultra RESILIA$2,606
MitraClip$947
Impella$278
EVOQUE$262
COREVALVE EVOLUT R$215
LUMASON$192
COROFLOW$179
ESPRIT$170
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$168
DRAGONFLY OPSTAR$156
NUVISION ICE CATHETER$132
Avalus$131
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$125
SYMPLICITY G3$115
LEQVIO$114

How this compares

$207,848 in reported general payments places this provider in the 90th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California →

Medicare billing

Part B allowed, 2024

$176,589

Medicare patients

1,007

Services billed

1,604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BrilintaTicagrelor	13	$9,070
Metoprolol Succinate	14	$98

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Orange

Brian KolskiOrange$534K
Jeffrey TylerOrange$411K
Arnold SetoOrange$214K
Matthew Pricela Jolla$2.3M
Frederick St GoarMountain View$2.2M
Saibal KarThousand Oaks$1.1M
Rahul SharmaStanford$1M
Puneet KhannaRancho Mirage$1M
Dennis SheehanRedwood City$900K
Suhail DohadBeverly Hills$802K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →